recently reported that NEDD9 could maintain the stem-like phenotype of ESCC cells by recruiting MDSCs via CXCL8, suggesting NEDD9 as a novel therapeutic target for ESCC (95). Here, NEDD9 is linked to esophageal squamous cell carcinoma.